Skip to main content

Transition from academia to industry: An interview with Elizabeth Paik

We have all read many articles about the possible career choices of a scientist. The usual dilemma is between industry and academia. We have talked about this in previous blogs but the more information we get the easier it is to make a wise choice. Of course we all have opinions about the pros and cons of such a choice but what I always find best is to ask people who have experienced both. That is why I turned to an old colleague and friend, Elizabeth Paik, and asked her some questions regarding her experiences in both academia and industry.

Can you describe to us your scientific career?
I started my career at Harvard Medical School, as a graduate student in Dr. Len Zon's laboratory. My thesis work focused on understanding a role of CDX transcription factors during embryonic hematopoiesis. Through ChIP-seq, knockdown and overexpression studies in zebrafish, I showed CDX transcription factors control expression of hematopoietic transcription factors - SCL and LMO2.

Towards the end of my PhD, ES and iPS field was blooming, and I got fascinated by how stem cells can be used to study human diseases. At the same time, I wanted to pursue translational research, having focused on basic biology during my PhD. I joined Dr. Lee Rubin's group at Harvard Stem and Regenerative Biology department. While in his lab, I used human iPS-derived dopaminergic neurons to study Parkinson’s disease. I also co-developed a purification method for midbrain dopaminergic progenitors to establish cell-based therapies for Parkinson’s disease.

After finishing my third year as a postdoc, I started my first job in industry as a scientist at CRISPR Therapeutics. I have been at CRISPR for nine months now, and it has been a very exciting and fulfilling experience.

Why did you choose to continue your career in industry?
I joined industry to pursue my interest in translational research. When I was a graduate student, colleagues in the Zon lab had discovered prostaglandin E2’s role in enhancing HSC self-renewal. Following the initial discovery, my adviser founded a biotech company focusing on translating this discovery into therapy. That was the first time when I saw how findings from an academic laboratory can be translated into therapies, and how industrial research can enable this transition. I thought being part of this later process would be very fulfilling.

I also liked the aspect of teamwork in industry. During my postdoc, I was working on a pharmaceutical company-funded project. The project was a highly collaborative one, where myself and two other postdocs worked towards establishing a stem cell therapy for Parkinson's disease. It was really exciting to work closely with them, and knowing that teamwork is a key in industry, I thought it would be a great fit for me. 

Do you use the knowledge that you received during your academic career for your industry career?
Being a research scientist, my daily job includes bench work, and designing experiments. I use skill sets that I acquired during my academic career every day. Back in graduate school, I had to custom-build many molecular biology tools because zebrafish had fewer ready-to-go reagents compared to other mammalian model organisms. Now that I am in a brand-new CRISPR field, I cannot rely on ready-made tools and even if there were tools out there, I have to run stringent quality checks on them. Therefore, my molecular biology skill sets earned during PhD years are extremely handy. 

Do you think it is easy to transition from academia to industry?
I think getting the first job in industry can be quite challenging. A lot of it depends on whether you are a good fit to the job requirements and the company culture. Because the job search can take a long time, it is important to stay positive through the process.

Do you feel you advance your scientific knowledge in industry?
Yes. Being in a small company, I need to be flexible and open to expand my knowledge of experimental tools and be creative regarding new ideas. For example, I learned a lot about the genome editing field since joining CRISPR Tx. 

What is the difference between research in academia and industry?
In industry, projects are goal-oriented, and have deadlines. You are expected to plan and execute in a timely manner so that you can achieve the milestones. You should be able to prioritize and efficiently use your resources to meet these expectations.

What would you advise someone who is lingering between an academic career and a career in industry?
I would actively reach out to people who already have a job in an industry and find out what it is like to work there. When I reached out to people, many candidly shared their experience, and I found it very helpful.  

Hopefully Elizabeth’s experience will be handy to many people looking for alternative careers out there. The key message is that transitioning to another job never wastes your prior knowledge. However, it takes time to find the right fit so you have to be patient, optimistic and take advice from the right people

Disclaimer: The views expressed here are solely those of the author and do not represent the views of the CRISPR Tx.





Elizabeth Paik, PhD
Scientist at CRISPR Tx
Cambridge, MA USA






Eirini Trompouki, PhD
ISEH Publications Committee Member

Group Leader
Max Planck Institute of Immunobiology and Epigenetics
Freiburg, Germany
http://www.ie-freiburg.mpg.de/trompouki

Comments

  1. Amazing interview with Elizabeth Paik. I'm going to bookmark this site for further detail about her. Here is a link http://www.qualitativeresearchcritique.com/professional-qualitative-research-analysis/. Hopefully you'll enjoy your visit here.

    ReplyDelete

Post a Comment

Popular posts from this blog

How to Make the Most Out of Your Lab’s Move

“The lab is moving!” I must confess, when I heard these words from my mentor about a year and a half ago, my heart dropped. Lab relocation experiences are some of the worst horror stories that you hear from fellow researchers: precious samples lost, mouse colonies never recovered, months spent re-establishing protocols. Moreover, it also meant I would have to leave San Francisco, a beautiful city that I loved to live in, and where I found many friends. Being a scientist often means not having much choice of geographic location of your work. The choice of a particular subject or even broad field usually requires a move to a new city, or even a new country. Moving with the lab means making this choice again – do I leave my project and all the progress behind, or do I accept the delay in my research and go ahead. Now, two months after our move to New York, I would like to reflect on my experiences and that of my fellow lab members on our cross-country relocation from the trainee perspect…

The cost of a postdoctoral experience and its impact on STEM diversity

Academic diversity in the biological sciences isn't what it should be.  At the most basic level, representation by underrepresented groups in the top research universities in the United States is less than 5%1.  Despite gains in enrollment of underrepresented students in the biological sciences at the undergraduate and doctoral levels, these gains do not extend to the tenure-track realm, where representation has changed very little over the past three decades. 

At another level, because of the ferocious degree of competition in science today - for publication in high impact journals, for limited grant funds, for fewer tenure-track positions -- one might argue that academic diversity is slowly been shaped by a "1%" mindset.  Perhaps more than ever before, the institution you come from-- even the lab you come from-- influences where you will publish, whether you will attain funding, and ultimately whether you will succeed. My purpose here is not to grumble; I'm sure th…

When people can…

As long as I can remember, there were people marching on the streets, either protesting or celebrating or even supporting the topic of the manifestation. It always fascinated me how powerful people can be, when they come together. In cases of manipulation of the public opinion this is of course not good. However, many times this can influence things in a positive way. Coming from a country like Greece, I have to admit that it was fairly frequent for me to see people getting together on the streets for a variety of reasons. Then, when I moved myself and my life to Boston, these events happened less frequently. I remember that I joined a protest in Boston once (although maybe this is not the right time to admit such a thing). It was about the Gulf war and people wanting their children to come back home. The subject of the protest was noble, however only a few people participated. Thus, it was to my great surprise and satisfaction when on April 22nd, 2017 the March for Science was organi…